NCT05747274 - SRDK0921_ Analytical Performance Study | Biotech Hunter

Enrollment

439

Participants

Timeline

Start Date

September 21, 2023

Primary Completion Date

September 29, 2023

Study Completion Date

September 29, 2023

Conditions

Kidney Transplant Rejection

Interventions

DEVICE

SRDK0921

SRDK0921 is an IVD composed of IVD kit for qPCR (SRDK0921KIT) and a cloud-based software (SRDK0921SOFT). It is a class C, rule 3k, IVD according to Regulation (EU) 2017/746.

Trial Locations (1)

44000

Nantes hospital, Nantes